Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Monthly Archives: April 2020

You are here:
  1. Home
  2. 2020
  3. April

Rameda values the role played by the Egyptian Pharmacists Syndicate and Pharmacies in serving patients across Egypt

Corporate NewsBy adminApril 28, 2020

Rameda issues statement regarding the “Stay Home to Protect your Family and Community” initiative

Corporate NewsBy adminApril 28, 2020

Rameda launches initiative for the complementary dispensary and home delivery of medication at no cost, underlining its dedication to ensuring the healthcare and safety of some of Egypt’s most immune-compromised patient populations amid the COVID-19 pandemic

Corporate NewsBy adminApril 26, 2020

EGX disclosure regarding the upcoming AGM on 10 May 2020

Regulatory DisclosuresBy adminApril 15, 2020

EGX Disclosure regarding Rameda’s Governance Report

Regulatory DisclosuresBy adminApril 15, 2020

EGX Disclosure on BOD and shareholding structure

Regulatory DisclosuresBy adminApril 13, 2020

EGX Disclosure on BOD and shareholding structure

Regulatory DisclosuresBy adminApril 12, 2020

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Acquires A Large Generic Product in a Sizable and Fast-Growing Therapeutic Area

Corporate NewsBy adminApril 1, 2020

EGX disclosure announcing the acquisition of a generic anti-inflammatory analgesic molecule

Regulatory DisclosuresBy adminApril 1, 2020

All Rights Reserved © 2024

Go to Top